Dynein mosaic type recombinant human type-B adenovirus and preparation method thereof

A technology of ciliated protein and adenovirus, applied in the field of genetic engineering, can solve the problems of lack of group B adenovirus and no research confirmation.

Active Publication Date: 2017-10-20
THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV (GUANGZHOU RESPIRATORY CENT)
View PDF5 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Mice are the most commonly used model animals. However, studies have shown that group B adenoviruses cannot infect mouse cells, while group C adenoviruses such as adenovirus type 5 can infect mouse cells; group B adenoviruses cannot infect golden hamster cells, Group C adenoviruses, such as type 5 adenoviruses, can infect golden hamster cells and replicate and proliferate. This difference may be caused by differences in ciliary proteins. Group B adenoviruses such as type 3 use human DSG2 protein as a receptor, while group C Adsorption receptors such as adenovirus type 5 are mainly CARs, but no studies have confirmed
At present, there is no animal model of group B adenovirus infection, so it is necessary to establish a small animal model of group B adenovirus infection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dynein mosaic type recombinant human type-B adenovirus and preparation method thereof
  • Dynein mosaic type recombinant human type-B adenovirus and preparation method thereof
  • Dynein mosaic type recombinant human type-B adenovirus and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Example 1 Preparation of ciliary protein chimeric recombinant human type 3 adenovirus rAd3E-FK5

[0038] The ciliary protein chimeric recombinant human type 3 adenovirus rAd3E-FK5 described in this example is based on the backbone plasmid pBRAd△E3GFP and recombinant human type 3 adenovirus rAd3E obtained by the inventor in the early stage (published documents are Zhang Q, Su X , SetoD, Zheng BJ, Tian X, Sheng H, Li H, Wang Y, Zhou R. Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector. Vaccine 2009; 27 (8): 1145-53) as the basis, replace the ciliary protein head gene of the recombinant human type 3 adenovirus rAd3E with the ciliary protein head gene of Ad5 (knob, amplified from the virus strain of Ad5, without mutation in amino acid sequence), And obtain the ciliary protein head replacement type recombinant adenovirus rAd3E-FK5, that is, the ciliary protein chimeric rec...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a dynein mosaic type recombinant human type-B adenovirus and a preparation method thereof. The skeleton of the dynein mosaic type recombinant human type-B adenovirus is a human type-B adenovirus genome, and a base sequence which encodes a receptor binding domain of dynein is a base sequence which encodes a corresponding domain of a human type-C adenovirus. By a molecular cloning method, Ad5-knob gene fragments are cloned and replaced to recombinant shuttle plasmids, in-vitro recombinant on the Ad5-knob gene fragments and a recombinant human type-3 adenovirus genome is realized, obtained knob gene fragments are replaced into type-5 recombinant human type-3 adenovirus genome, and therefore, dynein mosaic type recombinant human type-3 adenovirus rAd3-FK5 is obtained. The dynein mosaic type recombinant human type-3 adenovirus rAd3-FK5 can be infected with mouse primitive epithelial cells and golden hamster lung and kidney primitive cells in vitro, and the infection efficiency of the dynein mosaic type recombinant human type-3 adenovirus rAd3-FK5 is close to that of Ad5, and is much higher than that of a parent strain rAd3E, in golden hamster cells, significant copying exists, and the dynein mosaic type recombinant human type-B adenovirus can be used for small animal model research of human type-3 adenovirus vaccines and antiviral drug evaluation.

Description

technical field [0001] The invention belongs to the technical field of genetic engineering, and more specifically, the invention relates to a ciliary protein chimeric recombinant human type B adenovirus and a preparation method thereof. Background technique [0002] There are more than 60 types of human adenoviruses in 7 groups. Group B adenovirus types 3, 7, 14, and 55 are the main types that cause acute respiratory infection and severe pneumonia. Adenovirus capsid mainly includes ciliary protein, penton base and hexon. It is generally believed that hexon is the main neutralizing antigen of adenovirus, and ciliary protein is the receptor-binding protein that adsorbs cells. The main domain is located at the ciliary protein knob. [0003] Appropriate animal models are required for the evaluation of adenovirus vaccines, the evaluation of the efficacy of therapeutic drugs, and the study of pathogenic mechanisms. Mice are the most commonly used model animals. However, studies ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N7/01C12N15/34C12N15/861C12R1/93
CPCC12N7/00C12N15/86C12N2710/10321C12N2710/10322C12N2710/10343
Inventor 田新贵周荣刘甜恬周志超李潇
Owner THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV (GUANGZHOU RESPIRATORY CENT)
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products